Pay in 4 interest-free payments of $5.12 Learn more
Ships within 48 hours · Estimated delivery Nov 7 - Nov 12
Why your body depends on it daily
In addition to helping people with diabetes control symptoms, drugmakers say GLP-1 medicines improve cardiometabolic markers in both diabetic and non-diabetic patients with obesity
Side effects include bruising, swelling, and pain
A phase 2 clinical trial reported no difference in pain alleviation in patients with DN pain between ABT-639 and placebo and that ABT-639 showed no safety signals
The FDA has expanded approval for oral semaglutide a GLP-1 drug originally for diabetes to protect against heart attacks and strokes
US$ 22.22
US$ 28.48
US$ 22.76
US$ 29.65
